Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Dist...
FDA Recall #D-0150-2025 — Class II — November 22, 2024
Product Description
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Reason for Recall
Discoloration
Recalling Firm
Provepharm Inc. — Collegeville, PA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
2160 packs/5 ampules per pack = 10,800 ampules
Distribution
Nationwide within the United States
Code Information
Lot #: F9026F01, F9026F02, Exp. Date 12/2025
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated